Amgen cholesterol antibody feud could kill key IP rule

Nature Biotechnology 35, 1118 (2017).
doi:10.1038/nbt1217-1118

Author: Mark Ratner

Source: Nature Biotechnology - December 8, 2017 Category: Biotechnology Authors: Mark Ratner Tags: News Source Type: research